This case report highlighted the potential role of nutraceuticals as a treatment regime for managing FCGS in FIV-positive cats, particularly in cases resistant to traditional treatments.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:A nine-year-old female domestic shorthair cat presented with lethargy, anorexia, recurrent severe oral lesions, and oral pain.
📊
Key Findings & Data:Over a 2.5-month period, significant clinical improvements were observed, including resolution of oral lesions, increased appetite, and improved activity levels.
💡
Conclusion & Impact:This case report highlighted the potential role of nutraceuticals as a treatment regime for managing FCGS in FIV-positive cats, particularly in cases resistant to traditional treatments.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:Arginine · Cat · Iodine
Abstract
A nine-year-old female domestic shorthair cat presented with lethargy, anorexia, recurrent severe oral lesions, and oral pain. The cat was diagnosed with FCGS associated with FIV infection. Management was followed with a nutraceutical supplement including primarily iodine and arginine. Over a 2.5-month period, significant clinical improvements were observed, including resolution of oral lesions, increased appetite, and improved activity levels. This case report highlighted the potential role of nutraceuticals as a treatment regime for managing FCGS in FIV-positive cats, particularly in cases resistant to traditional treatments.
Erdoğan, S., Özalp, T., Erdoğan, H., Ural, K. (2025). Innovative Nutraceutical Approach in the Treatment of Chronic Gingivostomatitis: Insights Gained from the Case. Journal of Veterinary Case Reports, Volume: 5 Issue: 1. https://doi.org/10.5281/zenodo.15755450
Soltero-Rivera M, Goldschmidt S, Arzi B. Feline chronic gingivostomatitis current concepts in clinical management. J Feline Med Surg. 2023;25(8):1098612X231186834.
Older CE, Gomes MDOS, Hoffmann AR, et al. Influence of the FIV status and chronic gingivitis on feline oral microbiota. Pathogens. 2020;9(5):383.
Belgard S, Truyen U, Thibault JC, Sauter-Louis C, Hartmann K. Relevance of feline calicivirus, feline immunodeficiency virus, feline leukemia virus, feline herpesvirus and Bartonella henselae in cats with chronic gingivostomatitis. Berl Munch Tierarztl Wochenschr. 2010;123(9-10):369-376.
Ahmad AM, Ali OJ, Marif HF, Ali BA. Therapeutic Management of Chronic Gingivostomatitis In Cats. A Comprehensive Review. Basrah J Vet Res. 2024;23(3):156-169.
Bellei E, Dalla F, Masetti L, Pisoni L, Joechler M. Surgical therapy in chronic feline gingivostomatitis (FCGS). Vet Res Commun. 2008;32:231-234.
Szondi DC, Wong JK, Vardy LA, Cruickshank SM. Arginase signalling as a key player in chronic wound pathophysiology and healing. Front Mol Biosci. 2021;8:773866.
Paßlack N, Kohn B, Zentek J. Effects of arginine and ornithine supplementation to a high-protein diet on selected cellular immune variables in adult cats. J Vet Intern Med. 2020;34(2):852-856.
Druet I, Hennet P. Relationship between feline calicivirus load, oral lesions, and outcome in feline chronic gingivostomatitis (caudal stomatitis): retrospective study in 104 cats. Front Vet Sci. 2017;4:209.
Matsumoto H, Teshima T, Iizuka Y, Sakusabe A, Takahashi D, Amimoto A, Koyama H. Evaluation of the efficacy of the subcutaneous low recombinant feline interferon-omega administration protocol for feline chronic gingivitis-stomatitis in feline calicivirus-positive cats. Res Vet Sci. 2018;121:53-58.
1Johnston, N. (2012). An updated approach to chronic feline gingivitis stomatitis syndrome. Veterinary Practice, 44, 34-38.
1Mamo JC, Naissides M. Could iodine be effective in the treatment of human immunodeficiency virus and AIDS-associated opportunistic infections? Int J Infect Dis. 2005;9(5):292-293.
1Bingen A, Nonnenmacher H, Bastien-Valle M, Martin JP. Tissues rich in macrophagic cells are the major sites of feline immunodeficiency virus uptake after intravenous inoculation into cats. Microbes Infect. 2002;4(8):795-803.